Damage of the Bone Marrow Stromal Precursors in Patients with Acute Leukemia at the Onset of the Disease and During Treatment
Authors:
- Aleksandra SadovskayaASAleksandra Sadovskaya
- Nataliya PetinatiNPNataliya Petinati
- Irina ShipounovaISIrina Shipounova
- Nina DrizeNDNina Drize
- Igor SmirnovISIgor Smirnov
- Olga PobegutsOPOlga Pobeguts
- Georgiy ArapidiGAGeorgiy Arapidi
- Maria LagarkovaMLMaria Lagarkova
- Luiza KarasevaLKLuiza Karaseva
- Olga PokrovskayaOPOlga Pokrovskaya
- Larisa KuzminaLKLarisa Kuzmina
- Anastasia VasilievaAVAnastasia Vasilieva
Open Access
- 11 December 2024
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (24) , 13285
Abstract
In patients with acute leukemia (AL), malignant cells and therapy modify the properties of multipotent mesenchymal stromal cells (MSCs) and their descendants, reducing their ability to maintain normal hematopoiesis. The aim of this work was to elucidate the alterations in MSCs at the onset and after therapy in patients with AL. The study included MSCs obtained from the bone marrow of 78 AL patients (42 AML and 36 ALL) and healthy donors. MSC growth characteristics, gene expression pattern, proteome and secretome were studied using appropriate methods. The concentration of MSCs in the bone marrow, proliferative potential, the expression of several genes, proteomes and secretomes were altered in AL-MSCs. Stromal progenitors had been affected differently in ALL and AML patients. In remission, MSC functions remain impaired despite the absence of tumor cells and the maintenance of benign hematopoietic cells. AL causes crucial and, to a large extent, irreversible changes in bone marrow MSCs.Keywords
Funding Information
- Russian Science Foundation (22-15-00018)
This publication has 67 references indexed in Scilit:
- FLOT1 knockdown inhibits growth of AML cells through triggering apoptosis and pyroptosisAnnals of Hematology, 2023
- Ziyuglycoside II alleviates cyclophosphamide-induced leukopenia in mice via regulation of HSPC proliferation and differentiationBiomedicine & Pharmacotherapy, 2020
- The oncogenic role of Jagged1/Notch signaling in cancerBiomedicine & Pharmacotherapy, 2020
- Flotillin membrane domains in cancerCancer and Metastasis Reviews, 2020
- Exosomes from mesenchymal stem cells overexpressing MIF enhance myocardial repairJournal of Cellular Physiology, 2020
- A Cellular Taxonomy of the Bone Marrow Stroma in Homeostasis and LeukemiaCell, 2019
- The molecular signature of AML mesenchymal stromal cells reveals candidate genes related to the leukemogenic processCancer Letters, 2015
- COMP‐Ang1 promotes chondrogenic and osteogenic differentiation of multipotent mesenchymal stem cells through the Ang1/Tie2 signaling pathwayJournal of Orthopaedic Research, 2013
- Enhanced Angpt1/Tie2 signaling affects the differentiation and long-term repopulation ability of hematopoietic stem cellsBiochemical and Biophysical Research Communications, 2013
- Nestin expression ? a property of multi-lineage progenitor cells?Cellular and Molecular Life Sciences, 2004